An enzyme-linked immunosorbent assay for antibodies against acid soluble skeletal muscle antigen in myasthenia gravis

Simple item page
dc.contributorAnnamma, M
dc.contributorSarada, C
dc.contributorRadhakrishnan, VV
dc.date.accessioned2012-12-04T11:43:22Z
dc.date.available2012-12-04T11:43:22Z
dc.date.issued1999
dc.description.abstractAn enzyme-linked immunosorbent assay (ELISA) system has been developed for measuring serum antibodies against citric-acid extract of human skeletal muscles. With this assay, 80% of myasthenia patients with thymoma gave positive results. No sera from patients with neurological diseases other than myasthenia gravis (MG) gave positive results. The result of this study indicates that the ELISA system is useful as an adjunct for the diagnosis of MG particularly in the patients associated with thymoma and that the ELISA method can also be used as a prognostic marker following thymectomy in patients with MG.
dc.identifier.citationACTA NEUROLOGICA SCANDINAVICA. 100; 3; 175-177en_US
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/10478581
dc.identifier.urihttps://dspace.sctimst.ac.in/handle/123456789/102
dc.publisherACTA NEUROLOGICA SCANDINAVICA
dc.subjectImmunology
dc.titleAn enzyme-linked immunosorbent assay for antibodies against acid soluble skeletal muscle antigen in myasthenia gravis
Files
Collections
Journal Articles